Published in Cardiovasc Res on February 22, 2010
Myocardial function after polarizing versus depolarizing cardiac arrest with blood cardioplegia in a porcine model of cardiopulmonary bypass. Eur J Cardiothorac Surg (2016) 0.75
Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass. J Cardiothorac Surg (2011) 0.75
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res (2004) 2.44
Activation of myocardial contraction by the N-terminal domains of myosin binding protein-C. Circ Res (2006) 2.38
Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res (2005) 2.16
Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function. Hypertension (2013) 2.06
Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Eur J Cardiothorac Surg (2005) 2.03
Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ Physiol (2007) 1.77
Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem (2006) 1.58
Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res (2006) 1.56
Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J Biol Chem (2009) 1.47
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg (2002) 1.47
Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J (2003) 1.45
Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution. Interact Cardiovasc Thorac Surg (2008) 1.44
Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res (2007) 1.43
Does intermittent cross-clamp fibrillation provide equivalent myocardial protection compared to cardioplegia in patients undergoing bypass graft revascularisation? Interact Cardiovasc Thorac Surg (2009) 1.41
Ischaemic postconditioning: does cardioplegia influence protection? Eur J Cardiothorac Surg (2012) 1.39
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J (2005) 1.38
Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res (2006) 1.28
Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol (2003) 1.26
Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem (2002) 1.25
FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol (2009) 1.20
Antidepressants and falls in the elderly. Drugs Aging (2009) 1.19
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol (2012) 1.13
Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation (2010) 1.11
Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res (2003) 1.11
Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle. Circ Heart Fail (2009) 1.06
Novel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylation. J Biol Chem (2010) 1.05
FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation. Cardiovasc Res (2006) 1.05
Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J (2005) 1.02
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol (2010) 1.02
The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J (2007) 1.02
The rate of loss of T-tubules in cultured adult ventricular myocytes is species dependent. Exp Physiol (2010) 1.00
cMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance. J Muscle Res Cell Motil (2011) 0.99
Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol (2006) 0.97
Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol (2003) 0.93
Changes in P-selectin expression on cardiac microvessels in blood-perfused rat hearts subjected to ischemia-reperfusion. Ann Thorac Surg (2005) 0.93
Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol (2002) 0.93
Is there a transient rise in sub-sarcolemmal Na and activation of Na/K pump current following activation of I(Na) in ventricular myocardium? Cardiovasc Res (2003) 0.92
The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation. J Biol Chem (2011) 0.92
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle. J Pharm Pharmacol (2003) 0.92
A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle. J Biol Chem (2013) 0.91
Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol (2003) 0.91
Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase. FASEB J (2011) 0.90
Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia. Cardiovasc Res (2009) 0.90
Targeting for cardioplegia: arresting agents and their safety. Curr Opin Pharmacol (2009) 0.89
Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury. Am J Physiol Heart Circ Physiol (2010) 0.88
Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection. Cardiovasc Res (2006) 0.88
Novel regulation of cardiac Na pump via phospholemman. J Mol Cell Cardiol (2013) 0.87
Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? J Mol Cell Cardiol (2008) 0.87
The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts. Br J Pharmacol (2009) 0.86
Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae. J Physiol (2002) 0.86
Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but independent of MKK3. J Mol Cell Cardiol (2005) 0.85
From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene. J Muscle Res Cell Motil (2009) 0.83
Enhanced length-dependent Ca2+ activation in fish cardiomyocytes permits a large operating range of sarcomere lengths. J Mol Cell Cardiol (2010) 0.83
Plasma from patients with sepsis up-regulates the expression of CD49d and CD64 on blood neutrophils. Am J Respir Cell Mol Biol (2008) 0.83
Oxidative stress injury during cardiac surgery: how important is it? Cardiovasc Res (2007) 0.83
Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism. J Mol Cell Cardiol (2013) 0.83
Stereospecific synthesis of 1,2-cis glycosides by vinyl-mediated IAD. Org Lett (2004) 0.83
S-thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation. J Biol Chem (2002) 0.82
Cell volume control in phospholemman (PLM) knockout mice: do cardiac myocytes demonstrate a regulatory volume decrease and is this influenced by deletion of PLM? Exp Physiol (2008) 0.82
Long-term hypothermic lung preservation: does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg (2004) 0.81
Maternal dietary supplementation with saturated, but not monounsaturated or polyunsaturated fatty acids, leads to tissue-specific inhibition of offspring Na+,K+-ATPase. J Physiol (2008) 0.81
Regulation of the cardiac Na(+) pump by palmitoylation of its catalytic and regulatory subunits. Biochem Soc Trans (2013) 0.81
Responses to ischaemia and reperfusion in the mouse isolated perfused heart and the phenomenon of 'contractile cycling'. Clin Exp Pharmacol Physiol (2003) 0.81
Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin Exp Pharmacol Physiol (2007) 0.80
Inhibition of human mesangial cell proliferation by targeting T-type calcium channels. Nephron Exp Nephrol (2009) 0.80
Increased cardiovascular reactivity to acute stress and salt-loading in adult male offspring of fat fed non-obese rats. PLoS One (2011) 0.80
Purification of proteins susceptible to oxidation at cysteine residues: identification of malate dehydrogenase as a target for S-glutathiolation. Ann N Y Acad Sci (2002) 0.79
Ischemic preconditioning: a potential role for protein S-thiolation? Antioxid Redox Signal (2005) 0.79
Phospholemman and the cardiac sodium pump: protein kinase C, take a bow. Circ Res (2006) 0.79
Influence of isoprostane F2alpha-III on reflow after myocardial infarction. Eur Heart J (2004) 0.78
Future perspective of cardioplegic protection in cardiac surgery. J Nippon Med Sch (2013) 0.78
Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis. Am J Pathol (2013) 0.77
Myocardial infarction comes into the cold! Ann Thorac Surg (2009) 0.77
Evidence for a novel K(+) channel modulated by alpha(1A)-adrenoceptors in cardiac myocytes. Mol Pharmacol (2004) 0.76
ICVTS on-line discussion A. The safety of using millimolar doses of lidocaine as cardioplegia. Interact Cardiovasc Thorac Surg (2007) 0.75
Response to role of hyperleptinemia in the regulation of blood pressure and cardiac function. Hypertension (2014) 0.75
The salt of the earth: focus on Na⁺ regulation in the cardiac myocyte. J Mol Cell Cardiol (2013) 0.75
Is blood versus crystalloid cardioplegia relevant? Significantly improved protection may require new cardioplegic concepts! Interact Cardiovasc Thorac Surg (2008) 0.75
Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution. Eur J Cardiothorac Surg (2012) 0.75
Stereoselective synthesis of C-glycosides from carboxylic acids: the tandem Tebbe-Claisen approach. Org Biomol Chem (2003) 0.75
Stereoselective 1,2-cis glycosylation of 2-O-allyl protected thioglycosides. Chemistry (2002) 0.75
Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide. Ann Thorac Surg (2004) 0.75